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Redox balanceOxidative stress has been attributed both a key pathogenic and rescuing role in cerebral malaria (CM). In a
Plasmodium berghei ANKA murine model of CM, host redox signaling and functioning were examined during
the course of neurological damage. Host antioxidant defenses were early altered at the transcriptional level indi-
cated by the gradually diminished expression of superoxide dismutase-1 (sod-1), sod-2, sod-3 and catalase genes.
During severe disease, this led to the dysfunctional activity of superoxide dismutase and catalase enzymes in
damaged brain regions. Vitagene associated markers (heat shock protein 70 and thioredoxin-1) also showed a
decaying expression pattern that paralleled reduced expression of the transcription factors Parkinson disease
7, Forkhead box O 3 and X-box binding protein 1 with a role in preserving brain redox status. However, the ox-
idative stress markers reactive oxygen/nitrogen species were not accumulated in the brains of CM mice and
redox proteomics and immunohistochemistry failed to detect quantitative or qualitative differences in protein
carbonylation. Thus, the loss of antioxidant capacity was compensated for in all cerebral regions by progressive
upregulation of heme oxygenase-1, and in speciﬁc regions by early glutathione peroxidase-1 induction. This
study shows for theﬁrst time a scenario of cooperative glutathione peroxidase andhemeoxygenase-1 upregulation
to suppress superoxide dismutase, catalase, heat shock protein-70 and thioredoxin-1 downregulation effects in ex-
perimental CM, counteracting oxidative damage and maintaining redox equilibrium. Our ﬁndings reconcile the
apparent inconsistency between the lack of oxidative metabolite build up and reported protective effect of antiox-
idant therapy against CM.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Malaria caused by Plasmodium falciparum has the highest rates of
mortality in children because of its most life-threatening complication
cerebralmalaria (CM). This is an acute neurological condition character-
ized by seizures, metabolic acidosis, hypoglycaemia and coma [1]. CM
has a mortality rate of 10–14% and causes around 600,000 annual
deaths among young children predominantly in sub-Saharan Africa
and Southeast Asia [2]. Moreover, child survivors often show long-
standing neurocognitive sequelae, particularly in Africa [1,3].gía Molecular IV, Universidad
adrid, Spain. Tel.: +34 91 394
nd should be considered ﬁrst
, GlaxoSmithKline, 28760 Tres
ne, Public Health and Medical,
es, Rey Juan Carlos University,
ights reserved.Prior studies have attributed an important role in CM development
to an altered redox equilibrium. Some authors have suggested that reac-
tive oxygen species (ROS), produced by both host and parasite, accumu-
late during the development of this acute neurological condition
promoting oxidative stress [4–6]. The increased production of free rad-
icals (e.g. superoxide anion and hydroxyl radical) has been observed in
activated leucocytes, in endothelial cells during the adhesion of parasit-
ized red blood cells (pRBC) and, most strikingly, during hemoglobin di-
gestion in the parasite food vacuole [4,7–9]. This, in turn, causes protein
oxidation in the parasite and host membranes [10,11]. Indeed, en-
hanced host ROS production during the course of CM is thought to
play both a beneﬁcial and pathological role depending on the amount
and place of release. Beneﬁcial ROS effects contest parasite growth
whereas prolonged ROS exposure could cause cell damage in the host
brain [4,5]. In addition, several antioxidant treatments have shown pro-
tection against experimental cerebral malaria (ECM) and prevention of
persistent cognitive damage [6,12,13], suggesting the failure of host an-
tioxidant mechanism during CM. Notwithstanding, some studies have
failed to observe ROS accumulation and oxidative stress in brain during
CM [14], questioning the role played by these molecules in the patho-
genesis of this disease [8].
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vent oxidative stress, whereby the superoxide radical is reduced by su-
peroxide dismutase (SOD) to hydrogen peroxide, which is reduced to
water by both catalase (CAT), a peroxisomal enzyme with a central
function in brain cells, and glutathione peroxidase (GPX) [15]. More-
over, brain cells overcome oxidative stress through additional antioxi-
dant pathways such as those involving heat shock proteins (HSP),
heme oxygenase (HO), and thioredoxin (TRX) [16].
In the present study, we examined the state of these host antioxi-
dant defenses and their role in oxidative damage during the course of
the disease in a mouse ECM model. Here we report the dysfunction of
several host antioxidant systems associated with the reduced expres-
sion of transcription factors involved in preserving brain host redox sta-
tus. Oxidative stress markers failed to accumulate in brain regions in
parallel with the compensatory induction of two major antioxidant en-
zymes. Our results reconcile the controversial idea of a lack of oxidative
stress build up with the known protective effect of antioxidant therapy
against CM.
2. Materials and methods
2.1. Induction of malaria in mice and disease assessment
All experiments involving animals were conducted at the
Universidad Complutense de Madrid in accordance with national and
international guidelines for animal care. The study protocol was ap-
proved by the Animal Experimentation Committee of the Complutense
University at its meeting on February 11th 2011.
We used 44 ﬁve-weeks-old male C57BL/6 mice, as a CM susceptible
strain and 20ﬁve-weeks-oldmale BALB/cmice, as a non-susceptible CM
model. The animals were purchased from Harlan Ibérica (Barcelona,
Spain) and housed under standard conditions and supplied with food
and water ad libitum. In 32 C57BL/6 mice, CMwas induced by intraper-
itoneal injection of 5 × 106 P. berghei ANKA pRBC, as previously de-
scribed [17]. In a separate experiment 10 BALB/c mice were injected
with a similar number of P. berghei ANKA pRBC. Uninfected mice were
used as controls in both experiments. Our choice of using non-injected
animalswas based on the national and international regulations regard-
ing animal experimentation implemented at our University by the
Committee of Animal Experimentation aimed atminimizing animal suf-
fering. According to previous ﬁndings and reports [17,18], injected and
non-injected controlmice show identical behavior and histological phe-
notype during the experimental course, with no signs of disease or
distress.
The infected C57BL/6 mice developing CMwere monitored daily by
inspection of clinical signs and classiﬁed into 4 clinical stages using the
method of clustering animals by neurological symptoms as previously
described [17]. BALB/c mice were sacriﬁced when reaching the same
range of parasitemia than C57BL/6 mice. After their sacriﬁce by cervical
dislocation, the olfactory bulb, frontal cortex, hippocampus, thalamus–
hypothalamus, cerebellum and brainstem were immediately removed.
2.2. Mouse antioxidant system and transcription factor expression assays
Antioxidantmolecules and transcription factors (TF) mRNA levels in
olfactory bulb, frontal cortex, hippocampus, thalamus–hypothalamus,
cerebellum and brainstem were determined by quantitative reverse
transcriptase PCR (qRT-PCR) as previously described [18]. Speciﬁc
primers and probes for sod-1, sod-2, sod-3, gpx-1, cat, trx-1, ho-1,
hsp70, Parkinson disease 7 (park7), Forkhead box O 1 (foxo1), foxo3,
X-box binding protein 1 (xbp1) and the house keeping β-actin genes
(Assays-on-DemandTM Gene Expression products, TaqMan MGB
probes, Applied Biosystems, Warrington, UK) were used. The speciﬁcity
of the primers and probes used was veriﬁed by basic local alignment
search tool (BLAST) analysis, comparing the mouse genes selected
with the P. berghei genome and no signiﬁcant similarity was found.Theβ-actin gene served as an endogenous control to check for any slight
variation in the initial concentration, the total RNA quality and the con-
version efﬁciency of the reverse transcription reaction.
N-fold changes were calculated by expressing the amount of mRNA
for eachmolecule present in eachmouse vs. themean amount of mRNA
for the molecule detected in control mice.
2.3. CAT, SOD and GPX enzyme activity
100 μg of total brainstem and cerebellum protein extract from the
different groups of animals were loaded onto a 15% or 8% native acryl-
amide gel (for SODandGPXor CAT activity, respectively) in Tris–glycine
running buffer and run at 120 V. Enzyme activities were visualized as
described previously [19–21] as clear bands against a dark background.
In all assays, protein loading was determined by Coomassie Brilliant
Blue staining. Bands were quantiﬁed using Quantity-One 1-D analysis
software (Bio-Rad Laboratories Inc., Munich, Germany). Relative optical
densitywas calculated as the normalized enzyme activity in eachmouse
relative to the mean value obtained in control mice.
2.4. Reactive oxygen species/reactive nitrogen species (RNS)
Cerebella and brainstems from animals at stage IV of CM were ho-
mogenized in cold phosphate buffer and total ROS/RNS contents were
determined using the OxiSelectTM In Vitro ROS/RNS Assay Kit (Cell
Biolabs, Inc., San Diego, USA) following the manufacturer's instructions.
2.5. Protein carbonylation
2.5.1. Oxyblot analysis
Protein from control and CMcerebellawas extracted and derivatized
before 2D electrophoresis as previously described [22]. Derivatized pro-
teins were precipitated using trichloroacetic acid (TCA)-acetone and
resuspended in a buffer containing 7 M urea, 2 M thiourea, 4% 3-[(3-
cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS),
0.5% MEGA-10, and 10 mM dithioerythritol.
Proteinswere cup-loaded onto immobilized pHgradient (IPG) strips
(pH 3–11 NL, 18 cm) that had been previously hydrated overnight in a
buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 1.2% DeStreak and
0.5% ampholytes, pH 3–11. First-dimensional separationwas by isoelec-
tric focusing (IEF) using the IPGphor 3 IEF system (GE Healthcare, Buck-
inghamshire, UK) at 20 °C. The voltage was gradually ramped: 3 h
300 V, 6 h 300–1000 V, 3 h 1000–8000 V, and a ﬁnal step-n-hold at
8000 V for the next 7 h. The run was terminated after ~70,000 V h.
The focused strips were equilibrated in equilibration solution (50 mM
Tris 8.8, 6 Murea, 30% glycerol, 2% sodium lauryl sulfate (SDS)) contain-
ing 1% dithiothreitol reducing agent for 10 min, and transferred to 4%
iodoacetamide equilibration solution for a further 10 min. The second-
dimension SDS-PAGE was run on homogeneous 12.5% T and 2.6% C
casted polyacrylamide gels. Electrophoresis was carried out at 4 °C,
2 Wovernight using twoHoeffer units. For each experimental condition
(CM or control), 4 gels were run in parallel under identical 2D electro-
phoresis conditions. Two gels were stainedwith Sypro Ruby to visualize
total proteins and the other two gels were used for subsequent carbonyl
modiﬁed protein detection. These two gels prepared for CM and control
animals were transferred to polyvinylidene ﬂuoride (PVDF) membranes
and transfer efﬁciency was conﬁrmed by: (i) gel staining with Sypro
Tangerine before transfer and (ii) membrane staining with Sypro Ruby.
Any potential interference of Sypro Tangerine during immunodetection
was previously discarded. Carbonyl groups in the transferred mem-
branes containing derivatized proteins were immunodetected as previ-
ously described [22] using the anti-2,4-dinitrophenylhydrazone (DNP)
primary antibody (1/10,000, Sigma, Saint Louis, USA). Gel and immuno-
blot imageswere analyzed usingQuantity-One 1-D and PDQuest analysis
software (BioRad Laboratories Inc., Munich, Germany). The total amount
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ferred to the mean value obtained in control mice.
2.5.2. Immunohistochemistry
Control and infected mice were sacriﬁced and whole brains re-
moved and subjected to a cryoprotection process. 10-μm sagittal sec-
tions of brain tissue were cut using a Leica 3050 M cryostat and
incubated as described previously [23]. Speciﬁc detection of protein car-
bonylation was done by indirect peroxidase staining using the Elite
Vectastain kit (Vector Laboratories, Peterborough, UK) following the
manufacturer’s instructions. Chromogen reactions were performed
with diaminobenzidine (Sigma, Saint Louis, USA) and 0.003% hydrogen
peroxide for 10 min. Finally brain sections were coverslipped with
FluorsaveTM Reagent. Images were captured with Olympus DP50 digital
camera equipped to microscope Olympus BX50 using Studio Lite
computer.
2.6. Western blot analysis
Total tissue protein was extracted from the brainstem and cerebel-
lum of the different groups of animals. 10 μg of each protein extract
were separated on a 10% SDS-acrylamide gel and transferred to nitrocel-
lulose membranes and then blocked for 1 h using phosphate buffer-Fig. 1. Expression of sod and cat mRNA. sod-1, sod-2, sod-3 and catmRNA levels in the cerebel
detected in control (C) and CMmice at different disease stages (I–IV). Data are the mean ± sta
in the cerebellum: sod-1, sod-2, cat, P ≤ 0.001; sod-3, P ≤ 0.005; olfactory bulb: sod-1, sod-2, sod
cat, P ≤ 0.001; sod-3, P ≤ 0.005; hippocampus: sod-2, P ≤ 0.001; cat, P ≤ 0.01; sod-1, sod-3
P ≤ 0.05. *P ≤ 0.05.Tween 0.05% solution containing 5% non fat skimmed milk. Next, the
commercial polyclonal antibodies anti-HO-1 (1/1000, Assay Designs,
Ann Arbor, MI; Enzo Life Sciences Inc., Lausen, Switzerland) or anti-
glyceraldehyde 3-phospate dehydrogenase (GADPH) (1/10,000,
Applied Biosystems,Warrington, UK)were probed overnight at 4 °C. Fi-
nally, membranes were incubated 1 h at room temperature with horse-
radish peroxidase-conjugated anti-rabbit or anti-mouse IgG (1/5000,
GEHealthcare, Buckinghamshire, UK) and visualized by the ECLmethod
(SuperSignal West Pico Chemiluminescent Substrate Thermo Scientiﬁc,
Rockford, USA). Chemiluminescence images were quantiﬁed by densi-
tometry using Quantity-One 1-D analysis software (Bio-Rad Laborato-
ries Inc., Munich, Germany). Relative optical density was calculated as
the normalized expression of the enzyme in each mouse relative to
the mean value obtained in control mice.
2.7. Statistical analysis
Data are presented as the mean ± standard deviation. The Mann
Whitney U and Kruskal–Wallis non-parametric tests were used to com-
pare two or more groups respectively. Analyses were performed inde-
pendently for each molecule and region. All statistical tests were
performed using the SPSS 15.0 statistics package. The level of signiﬁ-
cance was set at a P ≤ 0.05.lum, olfactory bulb, brainstem, frontal cortex, hippocampus and thalamus–hypothalamus
ndard error of determinations in 5–7 animals. P values for signiﬁcant differences observed
-3, cat, P ≤ 0.001; brainstem: sod-1, sod-2, sod-3, cat, P ≤ 0.001; frontal cortex: sod-1, sod-2,
, P ≤ 0.05; and thalamus–hypothalamus: cat, P ≤ 0.001; sod-1, sod-2, P ≤ 0.005; sod-3,
Fig. 2.Activity of SOD (panel A) and CAT (panel B) in the brainstemand cerebellumof control (C) and stage IVCMmice (IV). Values given are themean ± standard error for 4 to 5 animals.
P values for signiﬁcant differences in SOD-1, SOD-2 and CAT activity observed in the brainstem and cerebellum, P ≤ 0.05. *P ≤ 0.05.
Fig. 3. Expression of hsp70 and trx-1 mRNA. Changes in the mRNA expression of hsp70
(panel A) and trx-1 (panel B) in the cerebellum (CB), olfactory bulb (O.B.), brainstem
(BS), frontal cortex (CX), hippocampus (HIP) and thalamus–hypothalamus (T-H) ob-
served in control (C) and CM mice at different disease stages (I–IV). Data are the
mean ± standard error of determinations in 5–7 animals. P values for signiﬁcant differ-
ences detected in hsp70: in all analyzed regions, P ≤ 0.001; trx-1: in O.B., P ≤ 0.005; BS,
P ≤ 0.01; CB, HIP, T-H, P ≤ 0.05. *P ≤ 0.05; NS, not signiﬁcant.
2012 M. Linares et al. / Biochimica et Biophysica Acta 1832 (2013) 2009–20183. Results
3.1. Expression of sod and cat during the clinical course of ECM
Host antioxidant systems are likely to play a major role in ROS de-
toxiﬁcation during CM. This action especially involves removal of the
superoxide radical and hydrogen peroxide by SOD and CAT. Three
types of SOD isoenzymes have been identiﬁed in brain: the widely
expressed cytosolic Cu/Zn-SOD (SOD-1), mitochondrial Mn-SOD
(SOD-2) and copper-and zinc-extracellular SOD (SOD-3) [24,25]. To ex-
amine the roles of these enzymes during CM,mRNA expression levels of
sod-1, sod-2, sod-3 and cat genes were determined by qRT-PCR during
the course of infection. Transcription levels of all these enzymes were
signiﬁcantly and steadily downregulated until stage IV, in all brain re-
gions examined (from 2 to 4 fold depending on the region), and were
most remarkably reduced in the brainstem, olfactory bulb and cerebel-
lum (Fig. 1).
3.2. Enzyme activities of SOD and CAT in ECM
The functionality of SOD and CAT proteins was addressed by native
gel electrophoresis and differential activity staining in two of the most
affected regions, brainstem and cerebellum, at the most severe disease
stage. These experiments revealed a band corresponding to the parasite
SODat the expected size formammalian SOD-2 (data not shown). How-
ever, despite the possible contribution of parasite SOD activity, both
SOD-1 and SOD-2 activities were signiﬁcantly reduced up to 3-fold in
CM stage IV, depending on the brain region examined (Fig. 2A). In par-
allel, CAT activity was signiﬁcantly reduced up to 1.5-fold (Fig. 2B).
3.3. Expression of hsp70 and trx-1 during the clinical course of ECM
HSP are part of an extended network of stress response genes and
cytoprotection genes called the vitagene system, which also includes
thioredoxins. Thesemolecules not only exert different antioxidant func-
tions but also act as key regulators of essential cell processes [16,26,27].
Among the different TRX isoforms, the cytoplasmic TRX (TRX-1) is
widely expressed in brain [16]. In this context, we examined possible
vitagene system modiﬁcations during CM progression by determininghsp70 and trx-1 mRNA expression. Thus, hsp70 mRNA was signiﬁcantly
and gradually downregulated until disease stage IV in all brain regions
(from2 to 5-fold, depending on the region) (Fig. 3A) and trx-1 expression
2013M. Linares et al. / Biochimica et Biophysica Acta 1832 (2013) 2009–2018was also downregulated (up to 4-fold) (Fig. 3B), the reduction being sig-
niﬁcant in all regions except the frontal cortex. The two molecules were
mostly downregulated in the brainstem and cerebellum.Fig. 5.Generation of ROS/RNS. Levels of ROS/RNSdetected in controlmice (C) and infected
mice at disease stage IV (IV) in the brainstem (BS) and cerebellum (CB). Data are the
mean ± standard error of determinations made in 3–5 animals calculated as nmol of
ROS/RNS normalized to each milligram of tissue in each animal. NS, not signiﬁcant.3.4. Expression of transcription factors in brain controlling antioxidant host
defenses
PARK7, XBP1 and the FOXO family of transcription factors regulate
the expression of several antioxidant enzyme genes, among them SOD,
CAT and TRX [28–30]. To investigate the potential role of these tran-
scription factors (TF) in the observed downregulation of antioxidant
molecules, we examined park7, foxo1, foxo3 and xbp1mRNA expression.
Host brain park7, foxo3 and xbp1 genes showed signiﬁcant steady
downregulation until stage IV up to 3-fold depending on the brain re-
gion. Again, the greatest variation was observed in the cerebellum and
brainstem (Fig. 4). The foxo1 expression pattern varied according to
brain region. Thus, besides the signiﬁcant gradual downregulation ob-
served in the olfactory bulb (up to 2-fold at stage IV), an early up-
regulation was observed in the frontal cortex and cerebellum (up to
1.3 fold at stage II) which then decreased as neurological symptomsFig. 4.mRNAexpression of park7, foxo1, foxo3 and xbp1 in the cerebellum, olfactory bulb, brainst
CMmice at different CMdisease stages (I–IV). Data are themean ± standard error of determina
xbp1, P ≤ 0.001; foxo3, P ≤ 0.005; olfactory bulb: park7, foxo1, xbp1, P ≤ 0.001; foxo3, P ≤
P ≤ 0.001; foxo3, P ≤ 0.01; foxo1, P ≤ 0.05; hippocampus: xbp1, P ≤ 0.001; park7, P ≤ 0.005
*P ≤ 0.05; NS, not signiﬁcant.progressed. This pattern was only statistically signiﬁcant for the cortex.
Although signiﬁcant changes were not observed in any other region, a
downregulation tendency was observed in the brainstem, hippocampus
and thalamus–hypothalamus (up to 1.5-fold at stages III–IV).em, frontal cortex, hippocampus and thalamus–hypothalamus observed in control (C) and
tions in 5–7 animals. P values for signiﬁcant differences detected in the cerebellum: park7,
0.005; brainstem: park7, xbp1, P ≤ 0.001; foxo3, P ≤ 0.005; frontal cortex: park7, xbp1,
; foxo3, P ≤ 0.05; and thalamus–hypothalamus: park7, xbp1, P ≤ 0.001; foxo3, P ≤ 0.05.
2014 M. Linares et al. / Biochimica et Biophysica Acta 1832 (2013) 2009–20183.5. Reactive oxygen species production and protein carbonylation in CM
To determine if the altered levels of antioxidant proteins observed
could lead to higher ROS production and intracellular oxidative stress,
we quantiﬁed reactive oxygen and/or nitrogen species (ROS/RNS) and
protein oxidation. ROS/RNS production (including the CAT substrate,
hydrogen peroxide and the superoxide by-product, peroxynitrite
anion) was evaluated in the two most affected regions, brainstem andB
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imals. NS, not signiﬁcant. The immunohistochemical distribution proﬁles of protein carbonyla
Images show the localization of carbonyl modiﬁed proteins in the cerebellum. Positive stainingcerebellum, at the most severe stage of infection (stage IV). However,
no signiﬁcant differences were observed between CM mice and
uninfected animals (Fig. 5).
ROS rapidly react with protein causing protein carbonylation, which
is one of the most common oxidation markers in biological systems
[31]. We thus explored the carbonyl contents of individual proteins and
the distribution pattern of protein carbonyls in the brains of CM mice at
the most severe disease stages by 2D oxyblot and immunohistochemicalIV
III-IV
8.5I
panel B) and immunohistochemical staining of protein carbonylation (panel C). Oxyblots
ined from control (C) or infectedmice at disease stages III and IV (III–IV). Images are rep-
mean ± standard error of two independent experiments using a pool of 2–3 different an-
tion in brain slices (panel C) were obtained from control (C) and stage IV CM mice (IV).
appears in dark brown color. Scale bar 50 μm.
2015M. Linares et al. / Biochimica et Biophysica Acta 1832 (2013) 2009–2018analyses. Similar 2D oxyblot patterns and spot numbers were observed
for cerebellum specimens obtained from CM or uninfected mice
(Fig. 6A). Thus, between technical replicates control mice showed 69
common spots and CM samples yielded 53 common spots. More than
90% of these CM spots were also present among the spots in control
mice. According to this analysis, it can be considered that protein carbon-
ylation in brain did not vary signiﬁcantly between infected and
uninfectedmice (Fig. 6B). To conﬁrm this, protein carbonylation distribu-
tion patterns were investigated by immunolabelling carbonyl groups in
all analyzed regions and again no differenceswere observed between ex-
perimental and control animals (Fig. 6C).
3.6. Expression of ho-1 and gpx-1 during the clinical course of ECM
The lack of correlation between the diminished functionality of the
antioxidant systems analyzed and oxidative stress production suggests
the compensatory antioxidant activity of other antioxidant systems. A
protective role against ECM has been assigned to ho-1 [32] and gpx-1
is also an essential gene in the brain antioxidant defense [15]. Both
could compensate for the partial lack of peroxide detoxiﬁcation by
CAT and TRX. Thus, we then examined the corresponding mRNA
expression level of ho-1 and gpx-1 genes during CM progression.
Remarkably, ho-1mRNA expression was progressively and signiﬁcantly
upregulated from disease stage 0 (controls) to IV by 7 to 37-fold
depending on the brain area. The greatest expression was observed in
the olfactory bulb, frontal cortex and brainstem (Fig. 7A). In contrast,
the gpx-1 expression pattern was not homogeneous across all brain re-
gions. Thus, although signiﬁcant downregulation was detected in the
brainstem (up to 2-fold at stage IV), an early up-regulation was ob-
served in most brain areas (up to 1.5-fold, depending on the region),
and signiﬁcantly higher gpx-1 mRNA levels were detected in theFig. 7.mRNA expression of ho-1 (panel A) and gpx-1 (panel B) in the cerebellum (CB), ol-
factory bulb (O.B.), brainstem(BS), frontal cortex (CX), hippocampus (HIP) and thalamus–
hypothalamus (T-H) detected in control mice (C) and CMmice at different disease stages
(I–IV). Data are themean ± standard error of determinations in 5–7 animals. P values for
signiﬁcant differences detected in ho-1: in all analyzed regions, P ≤ 0.001; and gpx-1: in
BS, P ≤ 0.005; CB, T-H, P ≤ 0.05. *P ≤ 0.05; NS, not signiﬁcant.cerebellum and thalamus–hypothalamus. Greatest increases were ob-
served at stage II (cerebellum, frontal cortex and hippocampus) or
stage I (thalamus–hypothalamus) since expression levels fell in later
disease stages (Fig. 7B).
3.7. Surplus of HO-1 and GPX in ECM
According to these results, we then determined the abundance of
both enzymes. HO-1 expression was analyzed by Western blot in
brainstem, one of the most affected regions, at the most severe stage
of the disease. This enzyme showed a signiﬁcant induction by 4.5 fold
in CM stage IV (Fig. 8A). On the other hand, as the greatest gpx-1 in-
creases were detected in cerebellum at stage II, these region and stage
were chosen for GPX differential activity staining experiments. The
band corresponding to GPX activity showed a signiﬁcant induction by
3-fold in CM mice compared with the controls (Fig. 8B).
3.8. Expression of sod, cat, ho-1 and gpx in a non-susceptible CM model
To compare our results with a malaria mice model that does not de-
velop the cerebral malaria syndrome, we determined, in brainstem and
cerebellum, the transcription levels of the most signiﬁcant enzyme
markers in BALB/c mice infected with P. berghei ANKA. We did not ob-
serve any change between infected and controls in the gpx and sod-3 ex-
pression in both brain regions analyzed. cat and ho-1 did not change
mRNA expression levels in brainstem but a minor variation was detect-
ed in cerebellum. On the other hand, sod-1 and sod-2 were slightly
downregulated in both regions, ranging from 1.3 to 2.0 fold (Table 1).
When changes were detected, they were notably lower than those ob-
served for these genes in CM susceptible mice.A
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Table 1
Comparison of mRNA expression in brainstem and cerebellum of infected BALB/c and C57BL/6 mice. N-fold changes are the mean ± standard error of determinations in 4–7 animals. P
values for signiﬁcant differences detected inmRNA expression analysis in BALB/c in brainstem: sod-1, P ≤ 0.01; sod-2, P ≤ 0.05; cerebellum: sod-2, cat and ho-1, P ≤ 0.01; sod-1: P ≤ 0.05;
C57BL/6-II in brainstem: sod-2 and ho-1, P ≤ 0.005; sod-1, P ≤ 0.05; in cerebellum: gpx-1, P ≤ 0.01; sod-2 and ho-1, P ≤ 0.05; C57BL/6-IV in brainstem: sod-1, sod-2, sod-3, cat and ho-1:
P ≤ 0.005; gpx-1: P ≤ 0.01; cerebellum: sod-1, sod-2, cat and ho-1: P ≤ 0.005; sod-3: P ≤ 0.05. Asterisk (*) indicates signiﬁcant differences (P ≤ 0.05) with respect to the corresponding
healthy control strain.
Gene BALB/c C57BL/6-II C57BL/6-IV Ratio
C57BL/
6-II vs.
BALB/c
C57BL/
6-IV vs.
BALB/c
Brainstem
sod-1 −0.248* ± 0.041 −0.157* ± 0.032 −0.397* ± 0.039 1 2
sod-2 −0.107* ± 0.023 −0.234* ± 0.033 −0.572* ± 0.034 2 5
sod-3 −0.021 ± 0.039 −0.060 ± 0.045 −0.304* ± 0.046 3 14
cat −0.010 ± 0.020 −0.153 ± 0.064 −0.484* ± 0.046 16 50
ho-1 0.008 ± 0.013 0.322* ± 0.048 0.980* ± 0.090 40 122
gpx-1 −0.013 ± 0.023 −0.025 ± 0.044 −0.216* ± 0.027 2 16
Cerebellum
sod-1 −0.129* ± 0.017 −0.056 ± 0.033 −0.287* ± 0.045 0 2
sod-2 −0.231* ± 0.042 −0.128* ± 0.024 −0.344* ± 0.052 1 1
sod-3 0.008 ± 0.046 0.043 ± 0.039 −0.257* ± 0.060 6 −34
cat −0.192* ± 0.014 −0.072 ± 0.035 −0.329* ± 0.057 0 2
ho-1 0.215* ± 0.043 0.254* ± 0.070 0.907* ± 0.056 1 4
gpx-1 0.076 ± 0.024 0.170* ± 0.036 0.040 ± 0.050 2 1
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According to the above results, we then determined the abundance
of SOD-1, SOD-2, CAT and HO-1 in cerebellum, since it was themost af-
fected region. None of these enzymes presented any change in terms of
protein activity or expression, respectively (Table 2). In addition, we
corroborated the absence of changes in the enzyme activity of GPX in
cerebellum and SOD-1 and SOD-2 in brainstem (data not shown).
4. Discussion
The generation of local oxidative stress factors during cerebral ma-
laria is still a matter of debate. Further, there is no general consensus
as to theprecise role played by oxidative stress in CM. To address the ox-
idative stress status of the infected host brain and its implications in the
neurocognitive damage produced by cerebral malaria, we examined a
broad set of oxidative stress markers and antioxidant defense systems
in host brain regions during the course of ECM.
In this experimental setting, we observed the functional failure of host
antioxidant defense system at the level of superoxide dismutase and cat-
alase enzyme activities in brain. Moreover, at the mRNA level, the signif-
icantly and gradually reduced expression of the three sod isoenzymes and
cat genes was seen to parallel the progression of neurological symptoms.
Both SOD and CAT mediate neuroprotective effects [24,33]. Altered ex-
pression levels and diminished activity of these two enzymes have been
reported in other neurological disorders [24,34,35]. Further, low levels
of both enzymes have also been detected in blood of human malaria pa-
tients [7,36]. In experimental mouse models, treatment with SOD or
CAT prolongs survival or prevents CM [5,12,24].
The SOD and CAT alterations detected in this study could be
explained, at least in part, by the hsp70 signiﬁcant downregulationTable 2
Comparison of enzyme activity of SOD-1, SOD-2 and CAT and protein expression of HO-1
in cerebellum of infected BALB/c and C57BL/6 mice. Relative values given are themean ±
standard error in 4–5 animals. P values for signiﬁcant differences in SOD-1, SOD-2, CAT and
HO-1 observed in C57BL/6, P ≤ 0.05. Asterisk (*) indicates signiﬁcant differences
(P ≤ 0.05) with respect to the corresponding healthy control strain. ND, not determined.
Protein BALB/c C57BL/6
SOD-1 1.130 ± 0.068 0.611* ± 0.109
SOD-2 1.095 ± 0.114 0.737* ± 0.099
CAT 0.892 ± 0.267 0.639* ± 0.100
HO-1 1.150 ± 0.124 N5* ± NDobserved during CM progression. The inducible chaperone HSP 70 reg-
ulates the enzymatic activities of SOD-1, SOD-2 and CAT [26,37] and
also plays a role in neuroprotection through an array of pro-survival ef-
fects [16,26,38]. TRX-1 is another component of the host antioxidant de-
fense systemwhich reduces peroxides and disulﬁde bridges in proteins
in concert with peroxyredoxins and TRX reductases and acts alone as an
antioxidant or ROS scavenger [16,27]. During the progression of ECM, in
parallel with cat, sod and hsp70 downregulation, trx-1 expression was
also signiﬁcantly reduced. Diminished TRX-1 levels have been observed
in the brains of patients with Alzheimer's disease [27] and their
upregulation has been linked to neuron survival following injury [16].
Thus, all these antioxidant molecules promote neuroprotection in
brain and their deﬁciency could lead to the neurodegeneration pro-
duced in CM. These changes observed in these molecules could explain
why antioxidants protect against CM [6,12,13] and suggest the use of
these antioxidant molecules as complementary therapeutic agents for
the management of cerebral malaria and to reduce its neurological se-
quelae. On the other hand, among the differences in local antioxidant
responses observed in the present study, the brainstem and cerebellum
were the most affected regions, as previously detected for other dys-
functional factors [17,18]. Alterations in these speciﬁc regions could ex-
plain someof CM's symptoms and sequelae, such as ataxia and impaired
movement and balance [1,3].
In the last 20 years, a number of transcription factors that mediate
critical transcription responses to oxidative stress have been identiﬁed
[39]. Thus, PARK7, XBP1 and the FOXO family of transcription factors reg-
ulate several antioxidant related genes [28–30]. In our study, the expres-
sion of foxo3, xbp1 and park7 was signiﬁcantly downregulated in all the
brain regions and, in general, foxo1 also showed this tendency. Therefore,
the mechanism underlying reduced antioxidant gene expression during
CM appears to be related to a decline in these TF. FOXO upregulates
sod-2 and cat expression [39,40], xbp1 knockdown has been found to de-
crease cat, sod-1 and trx-1 expression [29] and PARK7, that could act as an
antioxidant protein [41], can also modulate HSP70 and SOD-1 [42,43].
Uncontrolled oxidative stress could damage host antioxidant defenses
[5]. Hence, we examined ROS production and protein carbonylation, as
markers of oxidative stress. Oxidative stress has been observed in pRBC
by P. falciparum and P. berghei [5,10,11]. In addition, cerebral malaria
causes lipid peroxidation to a greater extent in human cerebrospinal
ﬂuid [44] than inmouse brain [6]. However, wewere unable to detect dif-
ferences in the accumulation of ROS in mice brain with severe stage CM
and uninfected controls. ROS rapidly react with proteins causing carbon-
ylation. Nevertheless, neither the level of protein carbonylation nor its
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Fig. 9. Redox regulation during ECM progression. The cartoon summarizes the hypothetical adaptation of redox systems during ECM. The diminished expression of SOD, CAT, TRX-1 (and
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in the brain of controlmice. The lack of alterations in total protein carbon-
yl contents in CM has been reported [14], and along with our results sug-
gests that ROS overproduction, if present, is well controlled in ECM and
plays no major role in its pathogenesis. On the other hand, given the ox-
idativemodiﬁcation of proteins predisposes them to proteolysis, some in-
creased protein carbonylation might not be readily detected [14].
Globally, our results could also be explained by the compensatory in-
duction of ho-1 and gpx-1 genes in several brain regions (Fig. 9). HO-1
production seems to be one of the earlier cellular responses to tissue
damage [16]. Bilirubin, one of the ﬁnal products of heme degradation
byHO-1, protects against the cytotoxic effects of the strong oxidants hy-
drogen peroxide and peroxynitrite [16,45,46]. Carbonmonoxide, anoth-
er by-product of the actions of HO-1, limits the production of free heme,
exerts anti-inﬂammatory actions [45] and suppresses the pathogenesis
of cerebral malaria in mice [32,47]. Increased levels of HO-1 have been
previously observed in CM as well as in other neurological diseases
[16,48,49]. On the other hand, GPX reduces hydrogen peroxide and or-
ganic hydroperoxides [15]. As mentioned above, xbp1 deletion reduces
several antioxidant enzymes but not gpx expression [29], supporting
the different gpx-1 expression pattern observed in our ECMmodel. Ele-
vated GPX activity has been observed in other neurological diseases
such as Alzheimer's [16] but, until now, its induction in CM had not
been described.
In this study, the changes observed in the analyzed redox markers
seem to be related to the cerebral syndrome of murine malaria. In a
non-cerebral malaria model (BALB/c infected with P. berghei ANKA),
only some of the markers analyzed showed minor changes in com-
parison to the changes observed in ECM. Moreover, those were not
translated into protein content or enzymatic activity. In addition these
ﬂuctuations seem to be dependent on the brain region.
5. Conclusions
In conclusion, these observations suggest a central role of antioxidant
systemsduring theprogress of cerebralmalariawhich is not accompanied
by the build-up of oxidative stress metabolites. The changes observed inthese systems during the course of CM open new perspectives for the
treatment of this disease. The pharmacological or nutritional manipula-
tion of endogenous cellular defense mechanisms is an innovative ap-
proach to therapeutic intervention [16]. In this context, the recently
reported protective effect of curcumin against ECM [50] could bemediat-
ed by inducing the heat-shock response coupled to other antioxidant ac-
tivities [16].
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